Programa de detección de fallas de calidad en los medicamentos comercializados
Defective drugs have been found during the postmarketing phase in various countries, regardless of those nations' level of economic development. This paper proposes guidelines for a program to uncover drug defects in the postmarketing surveillance period. Such a program should be run by a cente...
Published in: | Revista Panamericana de Salud Pública |
---|---|
Format: | Article in Journal/Newspaper |
Language: | English Spanish Portuguese |
Published: |
Pan American Health Organization
1999
|
Subjects: | |
Online Access: | https://doi.org/10.1590/s1020-49891999000800014 https://doaj.org/article/40409e5565064ef4b029efae7d21537f |
Summary: | Defective drugs have been found during the postmarketing phase in various countries, regardless of those nations' level of economic development. This paper proposes guidelines for a program to uncover drug defects in the postmarketing surveillance period. Such a program should be run by a center or service organized for that purpose within the framework of a national drug surveillance system. |
---|